Search Results - Stephane A Regnier
- Showing 1 - 6 results of 6
-
1
-
2
Mapping the Kansas City Cardiomyopathy Questionnaire (KCCQ) Onto EQ-5D-3L in Heart Failure Patients: Results for the Japanese and UK Value Sets by Matthias Hunger, Jennifer Eriksson, Stephane A. Regnier, Katsuya Mori, John A. Spertus, Joaquim Cristino
Published in MDM Policy & Practice (2020-11-01)Get full text
Article -
3
Impact of eptinezumab on work productivity beyond reductions in monthly migraine days: post hoc analysis of the DELIVER trial by Piero Barbanti, Susanne F. Awad, Heather Rae-Espinoza, Stephane A. Regnier, Xin Ying Lee, Peter J. Goadsby
Published in Journal of Patient-Reported Outcomes (2024-12-01)Get full text
Article -
4
Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab by Linus Jönsson, Susanne F. Awad, Stephane A. Regnier, Brian Talon, Steven Kymes, Xin Ying Lee, Peter J. Goadsby
Published in The Journal of Headache and Pain (2024-03-01)Get full text
Article -
5
Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study by Larry Charleston, Brian Talon, Christine Sullivan, Carlton Anderson, Steven Kymes, Stephane A. Regnier, Seema Soni-Brahmbhatt, Stephanie J. Nahas
Published in The Journal of Headache and Pain (2023-08-01)Get full text
Article -
6
NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings by Jörn M. Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, Andreas Tietz, Stephane A. Regnier, Gorana Capkun, Qin Ye, Jürgen Loeffler, Marcos C. Pedrosa, Matt Docherty
Published in Scientific Reports (2023-04-01)Get full text
Article